Tier 3 — preclinical
Loss of NAD Homeostasis Leads to Progressive and Reversible Degeneration of Skeletal Muscle
Cell metabolism
2016
24; 2; 269-282
Bibliography
- PubMed
- PMID 27508874
- PubMed Central
- PMC4985182
- Funding
- Indexed grant support includes NIAMS NIH HHS, NIDDK NIH HHS, NIA NIH HHS. The complete funding declaration is not specified in the accessible abstract.
- Competing interests
- A complete competing-interest declaration is not specified in the accessible publication information.
Study snapshot
| Design | Preclinical animal study with supporting assays as applicable |
|---|---|
| Model | Genetically modified and aging mice |
| Sample | Muscle-specific Nampt-depletion and aging mouse experiments |
| Intervention | NR rescue and genetic maintenance of NAD+ metabolism |
| Duration | Disease-rescue and aging protocols |
| Endpoints | Model-specific physiological outcomes; Biochemical or functional measures reported in the study |
What the study showed, in plain terms
Key findings
What this study can and cannot tell us
Editorial review
Reviewed by the Biohack Blueprint research team
Last verified



